12 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28214631	28	Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile.	China Pharmaceutical University
27341379	14	Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights.	Federal University of Minas Gerais
17011189	29	In silico identification and biochemical characterization of novel inhibitors of NQO1.	University of Manchester
21074425	44	In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).	University of Manchester and Manchester Cancer Research Center
20036559	31	Triazoloacridin-6-ones as novel inhibitors of the quinone oxidoreductases NQO1 and NQO2.	University of Manchester and Manchester Cancer Research Center
17999461	52	Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity.	University of Manchester
31514018	41	Discovery of potent 4-aminoquinoline hydrazone inhibitors of NRH:quinoneoxidoreductase-2 (NQO2).	University of Manchester
27829520	7	Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation.	China Pharmaceutical University
29803003	8	Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.	Nantong University
29712428	5	NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer.	China Pharmaceutical University
11809864	10	Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194).	Ucb Pharma
1347569	52	Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors.	Stanford University